Hemophilia A in United Arab Emirates
How patients in United Arab Emirates access treatment for hemophilia a via Named Patient Program.
About Hemophilia A
Hematology
Treatment access in United Arab Emirates
The UAE recognises a formal Named Patient / compassionate-use pathway via MOHAP and the Department of Health Abu Dhabi (DoH). Physicians apply on behalf of individual patients for drugs not registered in-country.
For patients in United Arab Emirates with hemophilia a whose required therapy is not locally registered, a Named Patient Program pathway typically applies.
How Reserve Meds supports patients with hemophilia a in United Arab Emirates
- Patient or physician contacts us with disease details and therapy requested.
- We verify eligibility in United Arab Emirates and confirm US supply.
- Treating physician in United Arab Emirates issues prescription and justification.
- We file United Arab Emirates-specific NPP/personal-import paperwork.
- We source the drug from a DSCSA-compliant US specialty wholesaler.
- Cold-chain shipment to the patient's physician or hospital pharmacy in United Arab Emirates.
Patient support throughout
- Case manager from request through delivery.
- Documentation translation where needed.
- Physician-to-physician support for clinical justification.
- Re-supply coordination for chronic therapy.